Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Organic Letters
|
April 12, 2003
Sequentially photocleavable protecting groups in solid-phase synthesis
Martin Kessler, Ralf Glatthar, Bernd Giese, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile
David Carcache, Ivo Vranesic, Joachim Blanz, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2009
Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity
Carsten Spanka, Ralf Glatthar, Sandrine Desrayaud, et al.
Journal of the American Chemical Society
|
May 9, 2002
Development of an enantioselective synthetic route to neocarzinostatin chromophore and its use for multiple radioisotopic incorporation
Andrew G Myers, Ralf Glatthar, Marlys Hammond, et al.
The Journal of Biological Chemistry
|
April 29, 2015
The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold
Sascha Gutmann, Alexandra Hinniger, Gabriele Fendrich, et al.
Journal of Medicinal Chemistry
|
May 1, 2024
Novel Inhibitory Site Revealed by <b>XAP044</b> Mode of Action on the Metabotropic Glutamate 7 Receptor Venus Flytrap Domain
Nunzia Cristiano, Alexandre Cabayé, Isabelle Brabet, et al.
Journal of Medicinal Chemistry
|
August 10, 2016
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors
Ralf Glatthar, Aleksandar Stojanovic, Thomas Troxler, et al.
The Journal of Biological Chemistry
|
March 6, 2014
Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior
Christine E Gee, Daniel Peterlik, Christoph Neuhäuser, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay
Thomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier, et al.
ACS Medicinal Chemistry Letters
|
April 22, 2022
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an <i>In Vivo</i> Efficacious TLR7/8 Antagonist
Claudia Betschart, Michael Faller, Florence Zink, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Organic Letters
|
April 12, 2003
Sequentially photocleavable protecting groups in solid-phase synthesis
Martin Kessler, Ralf Glatthar, Bernd Giese, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile
David Carcache, Ivo Vranesic, Joachim Blanz, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2009
Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity
Carsten Spanka, Ralf Glatthar, Sandrine Desrayaud, et al.
Journal of the American Chemical Society
|
May 9, 2002
Development of an enantioselective synthetic route to neocarzinostatin chromophore and its use for multiple radioisotopic incorporation
Andrew G Myers, Ralf Glatthar, Marlys Hammond, et al.
The Journal of Biological Chemistry
|
April 29, 2015
The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold
Sascha Gutmann, Alexandra Hinniger, Gabriele Fendrich, et al.
Journal of Medicinal Chemistry
|
May 1, 2024
Novel Inhibitory Site Revealed by <b>XAP044</b> Mode of Action on the Metabotropic Glutamate 7 Receptor Venus Flytrap Domain
Nunzia Cristiano, Alexandre Cabayé, Isabelle Brabet, et al.
Journal of Medicinal Chemistry
|
August 10, 2016
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors
Ralf Glatthar, Aleksandar Stojanovic, Thomas Troxler, et al.
The Journal of Biological Chemistry
|
March 6, 2014
Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior
Christine E Gee, Daniel Peterlik, Christoph Neuhäuser, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay
Thomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier, et al.
ACS Medicinal Chemistry Letters
|
April 22, 2022
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an <i>In Vivo</i> Efficacious TLR7/8 Antagonist
Claudia Betschart, Michael Faller, Florence Zink, et al.
Page
of 2